The story of Ginkgo Bioworks shows the challenges and progress in the emerging field of synthetic biology.
Herbicides are losing the war — and agriculture might never be the same again.
As a bioengineer, Linda Griffith once grew a human ear on the back of a mouse. Now she is reframing endometriosis — a “women’s disease” — as a key to unlocking some of biology’s greatest secrets.
In “Second Nature,” Nathaniel Rich offers a tour of the ways humans have both conquered the natural world and been overwhelmed by the unintended consequences.
Biologic drugs rack up billions in annual U.S. sales. Here’s a solution to lower the costs.
A slew of start-ups are engineering faux meats, eggs and dairy products that conjure a future in which we move from farm-to-table to lab-to-table.
Heroic work went into the development of the coronavirus vaccines. But that doesn’t mean this industry deserves your affection.
An artist project offering an absurdist take on the lab-grown meat industry triggers a debate and backlash in London.
With state and city government support, developers are building laboratories for medical research and incubator spaces for biotech start-ups amid the race for a coronavirus vaccine.
In “Editing Humanity,” Kevin Davies offers an account of Crispr at a moment when its leading American researcher has just won the Nobel Prize in Chemistry.
Impatient for a coronavirus vaccine, dozens of scientists around the world are giving themselves — and sometimes, friends and family — their own unproven versions.
Bayer faced tens of thousands of claims linking the weedkiller to cases of non-Hodgkin’s lymphoma. Some of the money is set aside for future cases.
Modern medicine still depends on this animal’s blood to test for bacteria in vaccines. And an alternative test requires further study.
The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.
Moncef Slaoui, a former pharmaceutical executive, is now overseeing the U.S. initiative to development coronavirus treatments and vaccines. His financial interests and corporate roles have come under scrutiny.
Moncef Slaoui, a former pharmaceutical executive the White House chose to lead a crash development program, acknowledged that the 12-18 month timeline cited by Dr. Anthony Fauci was already “very aggressive.”
The company announced that the Food and Drug Administration had cleared its application to proceed to a clinical trial involving about 600 people.
A pioneer of the gene-editing technology has devised a diagnostic test for the infection that could be as simple as a pregnancy test.
By some measures, it is winning the race, with four companies already testing their vaccine candidates on humans.
A team of scientists worked around the clock to evaluate 14 antibody tests. A few worked as advertised. Most did not.
A decade of health disinformation promoted by President Vladimir Putin of Russia has sown wide confusion, hurt major institutions and encouraged the spread of deadly illnesses.